Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
COVID vaccines: FDA to meet over Novavax
11:19am, Tuesday, 07'th Jun 2022
A Food and Drug Administration (FDA) advisory committee is meeting on Tuesday to discuss a request for emergency use authorization (EUA) for Novavax COVID vaccines.
NVAX Stock Alert: 14 Things to Know as the Novavax Vaccine Faces the FDA Today
11:18am, Tuesday, 07'th Jun 2022
Novavax (NVAX) stock is in the news today as investors prepare for the results from the vaccine company's meeting with the FDA. The post NVAX Stock Alert: 14 Things to Know as the Novavax Vaccine Face
Coronavirus Update: FDA panel set to review protein-based Novavax vaccine
10:55am, Tuesday, 07'th Jun 2022
An advisory panel to the U.S. Food and Drug Administration is meeting Tuesday to review the vaccine developed by Novavax Inc. as a potential fourth shot for American adults and will vote on whether th
Novavax Stock Halted Pending FDA Panel Meeting—Here's What To Know About The Company's Covid Vaccine
10:34am, Tuesday, 07'th Jun 2022
A federal advisory panel is set to vote on Tuesday on whether the FDA should authorize the company's Covid shot.
F.D.A. Advisers To Weigh In On Covid Shots by Novavax
05:19am, Tuesday, 07'th Jun 2022
Clinical trials found the vaccine to work well, but the company has long struggled with manufacturing.
Why Novavax Stock Dipped, Then Soared, on Monday
06:27pm, Monday, 06'th Jun 2022
The good news from a set of FDA briefing documents ultimately outweighed the bad news.
Novavax (NVAX) Down After FDA Raises Concern for Its COVID Jab
03:03pm, Monday, 06'th Jun 2022
Before deciding the fate of Novavax's (NVAX) COVID-19 vaccine, a document issued by the FDA suggests that the vaccine may cause heart problems like myocarditis/pericarditis.
Novavax faces high stakes FDA review this week that will decide the fate of its Covid vaccine in the U.S.
01:42pm, Monday, 06'th Jun 2022Novavax CCO ‘100% confident' doses of Novavax COVID-19 vaccine will be in U.S.
02:00am, Saturday, 04'th Jun 2022
John Trizzino, Novavax Chief Commercial Officer, joins Yahoo Finance Live to discuss the logistics associated with distributing the Novavax COVID-19 vaccine, pending the expected FDA decision to allow
Novavax COVID-19 vaccine nears authorization for U.S.
12:00am, Saturday, 04'th Jun 2022
John Trizzino, Novavax Chief Commercial Officer, joins Yahoo Finance Live to discuss the upcoming FDA decision to allow emergency use authorization for the Novavax COVID-19 vaccine on June 1.
FDA flags risk of myocarditis in Novavax COVID vaccine
05:37pm, Friday, 03'rd Jun 2022
Yahoo Finance senior health reporter Anjalee Khemlani looks at the FDA linking myocarditis to Novavax's COVID-19 vaccine, in addition to the rise in monkeypox cases in the U.S.
Novavax (NVAX) Stock Falls 25% on FDA Heart Inflammation Warning
12:28pm, Friday, 03'rd Jun 2022
Novavax (NVAX) stock is falling on Friday after the FDA requested a heart inflammation warning for the company's Covid-19 vaccine. The post Novavax (NVAX) Stock Falls 25% on FDA Heart Inflammation War
Novavax's stock slides 23% after FDA details myocarditis cases for COVID-19 vaccine candidate
11:40am, Friday, 03'rd Jun 2022
Shares of Novavax Inc. NVAX, -23.74% tumbled 22.9% in trading on Friday after the Food and Drug Administration published a report that detailed the agency's assessment of the clinical data for the com
Why Novavax Stock Is Plunging Today
11:18am, Friday, 03'rd Jun 2022
FDA briefing documents in advance of next week's advisory committee meeting highlighted potential safety issues with Novavax's COVID-19 vaccine.
Novavax Covid-19 Vaccine Linked to Heart Inflammation, FDA Says. The Stock Is Sliding.
11:09am, Friday, 03'rd Jun 2022
'Multiple events' of heart inflammation were reported after administering the Covid-19 vaccine, especially among younger men, according to the FDA.
